MARTHA BARR: Open Payments
NPI 1811366479 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 116 payments from 23 companies in 2025. Trend: 2023 $2,573 · 2024 $2,580 · 2025 $2,169
Food & beverage: $2,169
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $364 |
| Lilly USA, LLC | 14 | $296 |
| Axsome Therapeutics, Inc. | 5 | $195 |
| ABBVIE INC. | 14 | $182 |
| Novo Nordisk Inc | 11 | $157 |
| GlaxoSmithKline, LLC. | 17 | $157 |
| Amgen Inc. | 18 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $144 |
| Edwards Lifesciences Corporation | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
Products named: Korlym, Symbravo, TRELEGY ELLIPTA, Kerendia, KISUNLA, JARDIANCE, VRAYLAR, SAPIEN 3 Ultra RESILIA.
Industry payments across TX — which companies pay providers there.
